TY - JOUR
T1 - Phenotype-Genotype correlations and estimated carrier frequencies of primary hyperoxaluria
AU - Hopp, Katharina
AU - Cogal, Andrea G.
AU - Bergstralh, Eric J.
AU - Seide, Barbara M.
AU - Olson, Julie B.
AU - Meek, Alicia M.
AU - Lieske, John C.
AU - Milliner, Dawn S.
AU - Harris, Peter C.
AU - Langman, Craig
AU - Copelvitch, Lawrence
AU - Frishberg, Yaacov
AU - Edvardsson, Vidar
AU - Goldfarb, David
AU - Assimos, Dean
AU - Lowther, Todd
N1 - Publisher Copyright:
Copyright © 2015 by the American Society of Nephrology.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Primary hyperoxaluria (PH) is a rare autosomal recessive disease characterized by oxalate accumulation in the kidneys and other organs. Three loci have been identified:AGXT (PH1), GRHPR(PH2), andHOGA1 (PH3). Here, we compared genotype to phenotype in 355 patients in the Rare Kidney Stone Consortium PH registry and calculated prevalence using publicly available whole-exome data. PH1 (68.4% of families) was the most severe PH type, whereas PH3 (11.0% of families) showed the slowest decline in renal function but the earliest symptoms. A group of patients with disease progression similar to that of PH3, but for whom no mutation was detected (11.3% of families), suggested further genetic heterogeneity.We confirmed that the AGXT p.G170R mistargeting allele resulted in a milder PH1 phenotype; however, other potential AGXT mistargeting alleles caused more severe (fully penetrant) disease.We identified the first PH3 patient with ESRD; a homozygote for two linked, novel missense mutations. Population analysis suggested that PH is an order of magnitude more common than determined from clinical cohorts (prevalence, approximately 1:58,000; carrier frequency, approximately 1:70).We estimated PH to be approximately three times less prevalent among African Americans than among European Americans because of a limited number of common European origin alleles. PH3 was predicted to be as prevalent as PH1 and twice as common as PH2, indicating that PH3 (and PH2) cases are underdiagnosed and/or incompletely penetrant. These results highlight a role for molecular analyses in PH diagnostics and prognostics and suggest that wider analysis of the idiopathic stone-forming population may be beneficial.
AB - Primary hyperoxaluria (PH) is a rare autosomal recessive disease characterized by oxalate accumulation in the kidneys and other organs. Three loci have been identified:AGXT (PH1), GRHPR(PH2), andHOGA1 (PH3). Here, we compared genotype to phenotype in 355 patients in the Rare Kidney Stone Consortium PH registry and calculated prevalence using publicly available whole-exome data. PH1 (68.4% of families) was the most severe PH type, whereas PH3 (11.0% of families) showed the slowest decline in renal function but the earliest symptoms. A group of patients with disease progression similar to that of PH3, but for whom no mutation was detected (11.3% of families), suggested further genetic heterogeneity.We confirmed that the AGXT p.G170R mistargeting allele resulted in a milder PH1 phenotype; however, other potential AGXT mistargeting alleles caused more severe (fully penetrant) disease.We identified the first PH3 patient with ESRD; a homozygote for two linked, novel missense mutations. Population analysis suggested that PH is an order of magnitude more common than determined from clinical cohorts (prevalence, approximately 1:58,000; carrier frequency, approximately 1:70).We estimated PH to be approximately three times less prevalent among African Americans than among European Americans because of a limited number of common European origin alleles. PH3 was predicted to be as prevalent as PH1 and twice as common as PH2, indicating that PH3 (and PH2) cases are underdiagnosed and/or incompletely penetrant. These results highlight a role for molecular analyses in PH diagnostics and prognostics and suggest that wider analysis of the idiopathic stone-forming population may be beneficial.
UR - http://www.scopus.com/inward/record.url?scp=84942879171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942879171&partnerID=8YFLogxK
U2 - 10.1681/ASN.2014070698
DO - 10.1681/ASN.2014070698
M3 - Article
C2 - 25644115
AN - SCOPUS:84942879171
SN - 1046-6673
VL - 26
SP - 2559
EP - 2570
JO - Journal of the American Society of Nephrology : JASN
JF - Journal of the American Society of Nephrology : JASN
IS - 10
ER -